Combining longitudinal studies of PSA
From MaRDI portal
Recommendations
- A comparative study of approaches for predicting prostate cancer from longitudinal data
- Screening for prostate cancer using multivariate mixed-effects models
- Individual Prediction in Prostate Cancer Studies Using a Joint Longitudinal Survival–Cure Model
- scientific article; zbMATH DE number 2222299
- scientific article; zbMATH DE number 1140596
- Estimating Lead Time and Overdiagnosis Associated with PSA Screening from Prostate Cancer Incidence Trends
- Frequentist and Bayesian approaches for a joint model for prostate cancer risk and longitudinal prostate-specific antigen data
- scientific article; zbMATH DE number 6302931
- Development and validation of a dynamic prognostic tool for prostate cancer recurrence using repeated measures of posttreatment PSA: a joint modeling approach
Cited in
(4)- Calibrating disease progression models using population data: a critical precursor to policy development in cancer control
- Efficient parameter estimation in longitudinal data analysis using a hybrid GEE method
- Biomarker classification derived from finite growth mixture modeling with a time-varying covariate: an example with phosphorus and glomerular filtration rate
- Frequentist and Bayesian approaches for a joint model for prostate cancer risk and longitudinal prostate-specific antigen data
This page was built for publication: Combining longitudinal studies of PSA
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5701278)